BioXcel Therapeutics, Inc. (BTAI)
1.06
-0.02
(-1.85%)
USD |
NASDAQ |
Apr 10, 16:00
1.07
+0.01
(+0.94%)
After-Hours: 20:00
BioXcel Therapeutics EPS Diluted (Quarterly) : -1.028 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Rigel Pharmaceuticals, Inc. | 13.54 |
| Puma Biotechnology, Inc. | 0.2608 |
| Quince Therapeutics, Inc. | 0.00 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.54M |
| Revenue (Quarterly) | 0.256M |
| Total Expenses (Quarterly) | 12.80M |
| Enterprise Value | 119.35M |
| Gross Profit Margin (Quarterly) | 58.59% |
| Profit Margin (Quarterly) | -4.90K% |
| Earnings Yield | -674.7% |
| Normalized Earnings Yield | -602.58 |